The largest database of trusted experimental protocols

Strata x 33 m polymeric reversed phase

Manufactured by Phenomenex
Sourced in Germany

Strata-X 33 μm Polymeric Reversed Phase is a solid-phase extraction (SPE) product designed for sample preparation. It features a polymeric sorbent with a particle size of 33 μm, which is suitable for a variety of applications.

Automatically generated - may contain errors

4 protocols using strata x 33 m polymeric reversed phase

1

Pentosidine Quantification in Bone

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Pen content of the bone samples (TP) was analysed by HPLC as described by Greis et al. [34 (link)], with several modifications (introduction of a solid phase extraction, shortened gradient in HPLC). A total of 100 mg of bone powder were hydrolysed with 1 ml of 6 N HCl at 110 °C for 18 h. After drying, 1 ml of 0.01 M heptafluorobutyric acid (HFBA) was added. The solution was filtered through syringe filters (Ø 25 mm and 0.45 µm pore diameter), and solid phase extraction was performed (Phenomenex, Strata-X 33 µm Polymeric Reversed Phase). The dried samples were dissolved in 200 µl of pyridoxine-HFBA buffer. A total of 50 µl of each sample were injected into the HPLC system. The stationary phase was a semi-preparative column (Onyx™ Monolithic Semi-PREP C18, 100 × 4.6 mm) by Phenomenex. A linear gradient of acetonitrile (eluent B) and 0.1% HFBA in HPLC water (eluent A) was used as mobile phase with a flow rate of 1 ml/min over a period of 37 min, an extinction/emission wavelength of 335/385 nm for detection of pentosidine. Pen was identified by its retention time. A pentosidine standard (pentosidine 0.03303 nmol/ml in 0.01 M HFBA, Cayman Chemical) was used to establish a calibration curve.
+ Open protocol
+ Expand
2

Radiosynthesis Protocol for [18F]Fluoride

Check if the same lab product or an alternative is used in the 5 most similar protocols
All radiosyntheses were carried out using anhydrous DMF (Aldrich) and MeOH (Aldrich or Acros). Cu(MeCN)4OTf (Aldrich) was stored under argon. QMA cartridges (Sep-Pak Accell Plus QMA Carbonate Plus Light Cartridge) were obtained from Waters (Waters GmbH, Eschborn, Germany) and used without any preconditioning. RP-cartridges (Strata™-X 33 µm polymeric reversed phase, 200 mg/3 mL, tube) were from Phenomenex (Phenomenex Ltd., Aschaffenburg, Germany).
[18F]Fluoride was produced by the 18O(p,n)18F reaction by bombardment of enriched [18O]water with 16.5 MeV protons at the BC1710 cyclotron (The Japan Steel Works Ltd., Shinagawa, Japan) of the INM-5 (Forschungszentrum Jülich) or PETtrace 4 cyclotron (GE Healthcare, Uppsala, Sweden) at the IHB (Saint-Petersburg). If not otherwise noted, all radiolabeling experiments were carried out under ambient or synthetic air.
Standard deviations were calculated using standard formulae.
+ Open protocol
+ Expand
3

Solid Phase Extraction of Plasma Hormones

Check if the same lab product or an alternative is used in the 5 most similar protocols
Custom-made Solid Phase Extraction (SPE) cartridges were prepared by dry-packing 10 mg of polymer-based C18 sorbent (Strata-X 33µm polymeric reversed phase, Phenomenex) into 1-mL polypropylene pipette tips, the lower end of which were stoppered with a small piece of wool. Packed cartridges were mounted on a vacuum manifold (VM12 12-port vacuum SPE manifold, Phenomenex) and conditioned with 500 µL of methanol and 500 µL of water. Subsequently, a 200-µL aliquot of each plasma sample was diluted 1:1 with water and loaded onto a SPE cartridge. After a two-step washing procedure with 500 µL of water and 350 µL of methanol 40% v/v, the hormones were selectively eluted using 450 µL of pure methanol and collected in amber glass vials. The ow rate during SPE procedure was adjusted to 0.5 drop/sec. The eluates were spiked with 20 µL of internal standard solution (2 ng µL - 1 ), evaporated to dryness using a Centrivac VR-1 vacuum concentrator (Heraeus, Germany) and nally redissolved in 200 µL of methanol.
+ Open protocol
+ Expand
4

Cord Plasma and Placental Eicosanoid Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eicosanoid analysis was performed as previously described [35 (link)]. One hundred microliters of cord plasma and a total of 1 mg of protein from the placental homogenate were used for eicosanoid extraction. Briefly, after addition of a deuterated internal standard mixture, samples were added to MeOH (1:2), centrifuged, and then extracted using a solid phase extraction cartridge (Strata-X 33 µm Polymeric Reversed Phase, Phenomenex). Metabolites were eluted, dried down, reconstituted, injected onto an HPLC system (Shimadzu LC-10AD VP, Columbia, MD, USA) and separated on an HPLC column (Gemini C18, 150 × 2 mm, 5 µm, Phenomenex) directly interfaced into the electrospray source of a triple quadrupole mass spectrometer (5500 QTRAP, Sciex). Quantitation was performed using standard isotope dilution curves, as previously described [35 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!